Osaic Holdings’s iShares Evolved U.S. Innovative Healthcare ETF IEIH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,284
Closed -$75K 7762
2022
Q2
$75K Buy
2,284
+2
+0.1% +$66 ﹤0.01% 4647
2022
Q1
$5.19M Sell
2,282
-696
-23% -$23K 0.01% 1185
2021
Q4
$106K Sell
2,978
-137
-4% -$4.78K ﹤0.01% 4553
2021
Q3
$110K Buy
3,115
+4
+0.1% +$145 ﹤0.01% 4449
2021
Q2
$109K Buy
3,111
+2
+0.1% +$67 ﹤0.01% 4420
2021
Q1
$101K Buy
3,109
+757
+32% +$25.2K ﹤0.01% 4334
2020
Q4
$77K Sell
2,352
-258
-10% -$8.06K ﹤0.01% 4240
2020
Q3
$80K Sell
2,610
-288
-10% -$8.73K ﹤0.01% 3991
2020
Q2
$87K Buy
2,898
+100
+4% +$2.87K ﹤0.01% 3790
2020
Q1
$71K Buy
+2,798
New +$75.6K ﹤0.01% 3727

Osaic Holdings's IEIH Position: Q3 2022 in Review

Osaic Holdings sold out of iShares Evolved U.S. Innovative Healthcare ETF (IEIH) in Q3 2022, closing a stake of 2,284 shares — an estimated $75K sold.

Osaic Holdings first reported a position in IEIH in Q1 2020 and held it in 10 quarters. The position peaked at $5.19M in Q1 2022. 0 funds tracked by Wall St. Rank hold IEIH as of Q3 2022.

  • Osaic Holdings reported no remaining iShares Evolved U.S. Innovative Healthcare ETF position as of Q3 2022 after selling out during the quarter.
  • Osaic Holdings sold 2,284 iShares Evolved U.S. Innovative Healthcare ETF shares in Q3 2022, an estimated $75K.
  • Osaic Holdings first reported a position in iShares Evolved U.S. Innovative Healthcare ETF in Q1 2020 and held it in 10 quarters.
  • Osaic Holdings's iShares Evolved U.S. Innovative Healthcare ETF position peaked at $5.19M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held iShares Evolved U.S. Innovative Healthcare ETF as of Q3 2022.

Based on Osaic Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.